EUVIMEDEUVIMED entdecken
Crossref

Wilkins CR, Zwicker JI, Derkach A, Burge M. Impact of romiplostim on overall survival in chemotherapy induced thrombocytopenia. Blood . 2023;142(suppl 1):801-802.

Blood · 2024

DOI: 10.1182/blood.2024024692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood, 2024. Hauptthemen laut MEDLINE: Thrombocytopenia, Thrombopoietin, Receptors, Fc, Recombinant Fusion Proteins.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This American Society of Hematology annual meeting abstract has been retracted; please see Elsevier's Article Correction, Retraction and Removal Policy (Article withdrawal | Elsevier policy). This abstract has been retracted at the request of the Editors and the authors. The study’s authors conducted a reanalysis of their work, rematching the cohorts by including platelet count at the time of growth factor administration. They report that upon this reanalysis, both cohorts displayed similar survival, and thus the conclusions differed substantially and meaningfully from those stated in the abstract. To avoid any patient safety issues arising from this incorrect conclusion, the authors request retraction. All authors approve the retraction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombocytopeniaThrombopoietinReceptors, FcRecombinant Fusion ProteinsHumansAntineoplastic AgentsPlatelet CountFemaleMaleSurvival Rate

Substanzen

romiplostimThrombopoietinReceptors, FcRecombinant Fusion ProteinsAntineoplastic Agents

Zitieren

APA

(2024). Wilkins CR, Zwicker JI, Derkach A, Burge M. Impact of romiplostim on overall survival in chemotherapy induced thrombocytopenia. Blood . 2023;142(suppl 1):801-802. Blood. https://doi.org/10.1182/blood.2024024692

Vancouver

Wilkins CR, Zwicker JI, Derkach A, Burge M. Impact of romiplostim on overall survival in chemotherapy induced thrombocytopenia. Blood . 2023;142(suppl 1):801-802. Blood. 2024. doi:10.1182/blood.2024024692

BibTeX
@article{euvimed2024,
  title = {Wilkins CR, Zwicker JI, Derkach A, Burge M. Impact of romiplostim on overall survival in chemotherapy induced thrombocytopenia. Blood . 2023;142(suppl 1):801-802},
  journal = {Blood},
  year = {2024},
  doi = {10.1182/blood.2024024692}
}
Kostenlos starten →